Profile data is unavailable for this security.
About the company
QuantumPharm Inc is a China-based company principally engaged in the provision of drug discovery solutions and intelligent automation solutions. The Company operates its businesses through two segments. The Drug Discovery Solutions segment spans the full spectrum of the drug discovery and research process, providing modular standalone solutions to or collaborating with a diverse range of biotechnology and pharmaceutical companies and academic institutions for novel drug discovery endeavors. The Intelligent Automation Solutions segment includes solid-state research and development services and automated chemical synthesis services. Solid-state research and development services include computing services, wet laboratory services and comprehensive solutions.
- Revenue in HKD (TTM)214.45m
- Net income in HKD-2.76bn
- Incorporated2017
- Employees760.00
- LocationQuantumPharm IncSHENZHEN ChinaCHN
- Websitehttp://www.xtalpi.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beijing Balance Medical Technolgy Co Ltd | 439.23m | 112.15m | 18.66bn | 473.00 | 166.48 | 14.70 | -- | 42.47 | 0.7531 | 0.7531 | 2.96 | 8.53 | 0.3183 | 1.09 | 4.94 | 857,444.60 | 7.14 | 8.06 | 7.46 | 8.40 | 88.31 | 89.41 | 22.42 | 30.02 | 8.22 | -- | 0.0091 | 69.19 | 25.57 | 27.35 | 21.09 | 28.10 | 125.94 | -- |
| iRay Technology Co Ltd | 1.97bn | 611.59m | 18.97bn | 1.66k | 32.79 | 3.82 | -- | 9.61 | 3.74 | 3.74 | 12.14 | 32.15 | 0.2544 | 1.03 | 2.56 | 1,097,588.00 | 7.81 | 12.07 | 8.48 | 13.86 | 53.92 | 55.59 | 30.71 | 34.51 | 4.23 | -- | 0.3972 | 31.52 | 20.31 | 33.51 | -5.27 | 58.58 | 107.96 | -- |
| NIHON KOHDEN CORPORATION | 11.27bn | 483.47m | 19.41bn | 5.89k | 39.09 | 2.11 | 28.05 | 1.72 | 57.04 | 57.04 | 1,321.40 | 1,058.57 | 1.01 | 1.87 | 3.87 | 37,554,580.00 | 4.32 | 8.66 | 5.34 | 11.40 | 50.29 | 50.85 | 4.29 | 8.41 | 2.79 | -- | 0.0027 | 27.52 | 7.45 | 4.42 | -0.4909 | 8.75 | 8.05 | 11.75 |
| Hartalega Holdings Berhad | 3.52bn | 171.90m | 20.01bn | 9.04k | 116.01 | 2.40 | 47.68 | 5.69 | 0.0284 | 0.0284 | 0.5803 | 1.37 | 0.3768 | -- | 9.35 | 219,237.90 | 1.96 | 24.51 | 2.10 | 28.28 | -- | 46.45 | 5.19 | 29.23 | 4.80 | 19.75 | 0.0097 | 45.57 | -23.72 | -8.25 | 105.32 | -51.27 | -17.35 | -46.78 |
| Eyebright Medical Tchnlgy Beijing Co Ltd | 1.47bn | 400.27m | 20.73bn | 2.07k | 51.71 | 8.21 | -- | 14.09 | 1.95 | 1.95 | 7.17 | 12.29 | 0.4599 | 2.40 | 4.64 | 654,939.80 | 11.73 | 9.99 | 13.29 | 11.16 | 65.58 | 81.29 | 25.50 | 34.66 | 3.76 | 41.18 | 0.1904 | 19.91 | 64.14 | 49.59 | 30.63 | 71.80 | 38.83 | -- |
| Alfresa Holdings Corporation | 147.05bn | 1.62bn | 22.56bn | 12.52k | 12.85 | 0.831 | 9.70 | 0.1535 | 169.96 | 169.96 | 15,444.13 | 2,628.07 | 2.00 | 16.85 | 4.37 | 230,646,200.00 | 2.17 | 2.27 | 6.01 | 5.93 | 7.26 | 7.25 | 1.09 | 1.13 | 1.05 | -- | 0.0576 | 37.85 | 6.02 | 1.60 | 14.63 | -6.66 | 2.32 | 7.39 |
| QuantumPharm Inc | 214.45m | -2.76bn | 22.70bn | 760.00 | -- | 5.06 | -- | 105.85 | -1.08 | -1.08 | 0.1037 | 1.31 | -- | -- | -- | 273,886.60 | -- | -- | -- | -- | -- | -- | -1,280.46 | -- | -- | -- | 0.038 | -- | 30.80 | -- | -33.08 | -- | -- | -- |
| MGI Tech Co Ltd | 2.79bn | -945.53m | 22.96bn | 2.87k | -- | 2.65 | -- | 8.23 | -2.12 | -2.12 | 6.26 | 19.21 | 0.2467 | 0.7745 | 2.87 | 898,663.20 | -8.40 | -- | -9.62 | -- | 59.99 | -- | -34.04 | -- | 3.99 | -- | 0.0766 | -- | -31.19 | -- | -129.98 | -- | -- | -- |
| Shandong Weigao Group Medical Polymer Co | 14.11bn | 2.08bn | 22.99bn | 12.61k | 10.92 | 0.9156 | 7.28 | 1.63 | 0.4605 | 0.4605 | 3.12 | 5.49 | 0.3787 | 2.81 | 2.05 | 1,127,114.00 | 5.76 | 7.89 | 7.47 | 10.08 | 49.94 | 55.03 | 15.21 | 18.65 | 2.89 | 12.31 | 0.1436 | 30.03 | -3.77 | 8.47 | -27.57 | 6.33 | -2.93 | 10.76 |
| Ansell Ltd | 12.41bn | 586.30m | 24.31bn | 15.95k | 37.23 | 1.67 | 21.13 | 1.96 | 0.8741 | 0.8741 | 18.74 | 19.53 | 0.561 | 2.02 | 8.03 | 152,016.80 | 2.68 | 6.11 | 3.16 | 7.33 | 38.58 | 37.78 | 4.79 | 8.97 | 2.75 | 15.07 | 0.3098 | 43.55 | -2.16 | 1.56 | -48.42 | -7.29 | 7.57 | -4.12 |
| Poly Medicure Ltd. | 1.40bn | 271.62m | 25.96bn | 2.65k | 90.83 | 10.87 | 76.62 | 18.51 | 30.62 | 30.62 | 158.16 | 255.82 | 0.6411 | 2.11 | 5.24 | 5,742,980.00 | 12.42 | 13.16 | 14.70 | 16.12 | 66.50 | 55.62 | 19.37 | 16.69 | 3.97 | 30.38 | 0.0584 | 15.10 | 23.36 | 17.63 | 44.05 | 31.61 | 28.85 | 8.45 |
Data as of Nov 08 2024. Currency figures normalised to QuantumPharm Inc's reporting currency: Hong Kong Dollar HKD
0.14%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Bellevue Asset Management AGas of 30 Aug 2024 | 4.50m | 0.13% |
| Phillip Capital Management (S) Ltd.as of 03 Oct 2024 | 115.00k | 0.00% |
| Fideuram Asset Management (Ireland) DACas of 30 Sep 2024 | 24.00k | 0.00% |
| Renaissance Capital LLCas of 03 Oct 2024 | 11.00k | 0.00% |
More ▼
Data from 30 Jun 2024 - 04 Oct 2024Source: FactSet Research Systems Inc.
